PRESS RELEASE published on 02/01/2023 at 15:45, 1 year 8 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 1 year 8 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 1 year 8 months ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 1 year 9 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 1 year 9 months ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 1 year 9 months ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 1 year 9 months ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
PRESS RELEASE published on 01/20/2023 at 18:45, 1 year 9 months ago Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
PRESS RELEASE published on 01/20/2023 at 14:30, 1 year 9 months ago Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st
PRESS RELEASE published on 01/12/2023 at 01:10, 1 year 9 months ago REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Der
Published on 10/30/2024 at 01:15, 3 hours 17 minutes ago LQWD Grants Incentive Stock Options to Key Management
Published on 10/29/2024 at 22:10, 6 hours 22 minutes ago Electric Metals Announces DSU and Stock Option Grant
Published on 10/29/2024 at 20:15, 8 hours 17 minutes ago Tenth Avenue Petroleum Executes Definitive Agreement To Acquire Low Decline, Production In Southern Alberta
Published on 10/30/2024 at 04:12, 20 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus 2024 AGM Chair and CEO address
Published on 10/30/2024 at 00:17, 4 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: September 2024 quarter update
Published on 10/29/2024 at 23:56, 4 hours 35 minutes ago grenke publishes preliminary figures for the third quarter of 2024
Published on 10/29/2024 at 23:23, 5 hours 8 minutes ago EQS-Adhoc: grenke reduces Group earnings guidance
Published on 10/29/2024 at 20:34, 7 hours 57 minutes ago EQS-Adhoc: Daimler Truck Holding AG: Release
Published on 10/29/2024 at 17:40, 10 hours 52 minutes ago Mersen to acquire Bar-Lo carbon products to consolidate its material strategy in the United States
Published on 10/29/2024 at 17:40, 10 hours 52 minutes ago Mersen acquiert Bar-Lo Carbon Products pour consolider sa stratégie matériaux aux États-Unis
